Skip to content
Start-Up Stories
News
Events
Funding
Contact Us
Main Menu
About Us
Menu Toggle
About Us Menu
About Us
Our People
Education Programmes
Menu Toggle
NUS Overseas Colleges Template
NUS Overseas Colleges
NOC Story
Programmes
Curriculum Overview
Our NOC Locations
Apply
Application Info
Apply Now
Awards and Scholarships
FAQ
N-House
N-House Resident Mentor/Advisor
Our Alumni
Partnership Opportunities
NUS Enterprise Summer Programme in Entrepreneurship Template
NUS Enterprise Summer Programme in Entrepreneurship
NUS Enterprise Winter Programme in Entrepreneurship Template
NUS Enterprise Winter Programme in Entrepreneurship
NUS Master of Science (MSc) in Venture Creation Template
NUS Master of Science (MSc) in Venture Creation
Our Alumni
Supporting Entrepreneurs
Menu Toggle
NUS Start-up Runway Template
NUS Start-up Runway
Early & Growth Stage
BLOCK71 Global Ecosystem
Connect
PIER71
CyberSG TIG Collaboration Centre
InnovFest
Polkadot Blockchain Academy @ NUS
Societal Impact Initiatives Template
Societal Impact Initiatives
Philip Yeo Initiative
Innovation with Societal Impact
Innovation for Impact Pledge
Joint Initiative on Social System Innovation
Funding Template
Funding
Partnering Corporates
Menu Toggle
Partnering Corporates Template
Corporate Partnerships
Friends of NUS Enterprise
Accelerators & Challenges
PIER71
ICE71
InnovFest
Research and Resources
Menu Toggle
Research and Resources Menu
Research Projects
Research Publications
TechASEAN
Newsletter
Videos
NUS Innovation and Venture Creation (IVC) Awards
Technology to Innovation
Quick Links
Menu Toggle
Quick Links Template
Start-Up Stories
News
Events
Funding
Contact Us
/
News
/ By
Homepage
News
AgeX Therapeutics Acquires Technology to Regulate Immune Tolerance
Share
Tweet
Print
